Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, is pleased to announce that its Chief Operating Officer and Co-founder, Dr. Rahul Kushwah, will be presenting at the prestigious 25th MK Investment Conference in Munich, Germany, on October 1, 2025.
The MK Investment Conference, hosted by Michael Kott and CM-Equity AG, is one of Europe’s most anticipated investment gatherings. A large and diverse investor audience is expected to attend, with strong interest in AI, Longevity, Tech, and ESG sectors. The event serves as a gateway to exclusive investment opportunities, including innovative private companies and upcoming IPOs.
“AI is the major tech theme today. AI touches all lives, and our technology is built with that self-evident intent,” said Dr. Rahul Kushwah, COO of Predictmedix AI. “At Predictmedix, we are positioned in the sweet spot of the AI revolution—delivering real-world solutions with meaningful impact in healthcare and beyond.”
Predictmedix AI’s presentation will highlight its proprietary AI-powered technologies, designed to redefine health management, clinical trials and screening with greater accessibility, efficiency, and scale. With investor appetite for AI at an all-time high, the Company looks forward to sharing its growth vision, milestones, and investment potential with global capital market leaders in Munich.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!